
Potential biomarkers of long-term benefit from single-agent trastuzumab or lapatinib in HER2-positive metastatic breast cancer
Montemurro, Filippo, Prat, Aleix, Rossi, Valentina, Valabrega, Giorgio, Sperinde, Jeff, Peraldo-Neia, Caterina, Donadio, Michela, Galván, Patricia, Sapino, Anna, Aglietta, Massimo, Baselga, José, ScalVolume:
8
Langue:
english
Journal:
Molecular Oncology
DOI:
10.1016/j.molonc.2013.08.013
Date:
February, 2014
Fichier:
PDF, 323 KB
english, 2014